BACCX
Price
$18.80
Change
-$0.04 (-0.21%)
Updated
Aug 21 closing price
Net Assets
386.77M
VENAX
Price
$89.68
Change
-$0.06 (-0.07%)
Updated
Aug 21 closing price
Net Assets
12.38B
Interact to see
Advertisement

BACCX vs VENAX

BACCX vs VENAX Comparison Chart in %
View a ticker or compare two or three
VS
BACCX vs. VENAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BACCX is a Hold and VENAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 12.4B vs. BACCX (387M). VENAX pays higher dividends than BACCX: VENAX (2.40) vs BACCX (1.19). BACCX was incepted earlier than VENAX: BACCX (22 years) vs VENAX (22 years). BACCX (2.01) is less costly to investors than VENAX (0.09). BACCX is a more actively managed with annual turnover of: 66.00 vs. VENAX (11.00). BACCX has a lower initial minimum investment than VENAX: BACCX (1000) vs VENAX (100000). VENAX (48.08) and BACCX (47.29) have marching annual gain over last year. BACCX (185.87) and VENAX (181.39) have equivalent 5 years return.
BACCXVENAXBACCX / VENAX
Total Expense Ratio2.010.092,233%
Annual Report Gross Expense Ratio2.010.092,233%
Fund Existence22 years22 years-
Gain YTD40.63542.55395%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets387M12.4B3%
Annual Yield % from dividends1.192.4050%
Returns for 1 year47.2948.0898%
Returns for 3 years58.0346.44125%
Returns for 5 years185.87181.39102%
Returns for 10 years119.5885.74139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTC13.480.47
+3.61%
Benitec Biopharma
DBD69.942.13
+3.14%
Diebold Nixdorf
FMS23.43N/A
N/A
Fresenius Medical Care AG
NHPAP25.21N/A
N/A
National Healthcare Properties Inc
CSBR4.97-0.21
-4.05%
Champions Oncology